Aligos Therapeutics, Inc. Other Assets, Noncurrent
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $759.00K.
- 2026-03-31: Other Assets, Noncurrent $759.00K.
- 2025-12-31: Other Assets, Noncurrent $715.00K.
- 2025-09-30: Other Assets, Noncurrent $713.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $759.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $759.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $715.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $713.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $640.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $632.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $627.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $635.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $631.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $625.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $625.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $623.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $624.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $632.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $634.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $653.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | $616.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $616.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | $866.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $748.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.48M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $188.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $377.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $2.84M 10-Q · filed 2020-11-25 |
| 2019-12-31 | $188.00K 10-K · filed 2021-03-23 |